Company: MDCXW
Filing Date: 2025-09-19
Form Type: DRS
Source: 0001062993-25-015719
Chunk: 285

Company: Medicus Pharma Ltd.
Filing Date: 2025-09-19
Form: DRS
Chunk 285
---
 Exhibit 10.2 to the Registrant's Current Report on Form 8-K, filed with the SEC on May 5, 2025).                                                                                    |

<div align='center'>II-7

CONFIDENTIAL TREATMENT REQUESTED BY MEDICUS PHARMA LTD.PURSUANT TO 17 C.F.R. SECTION 200.83</div>

| 10.13 
 10.14 | Form of Warrant Inducement Agreement (incorporated by reference from Exhibit 10.1 to the Registrant's Current Report on Form 8-K, filed with the SEC on July 14, 2025)                                                                                                            
 Employment Agreement, dated June 13, 2025, by and between Medicus Pharma Ltd. and Andrew Smith (incorporated by reference from Exhibit 10.3 to the Registrant's Quarterly Report on Form 10-Q, filed with the SEC on August 11, 2025)                                             |
|:------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 10.15 | Securities Purchase Agreement, by and between Medicus Pharma Ltd. and YA II PN, Ltd., dated September 17, 2025 (incorporated by reference from Exhibit 10.1 to the Registrant's Current Report on Form 8-K, filed with the SEC on September 18, 2025).                            |
| 10.16 | Global Guaranty Agreement, by and among the subsidiaries of Medicus Pharma Ltd. set forth in Schedule I thereto, dated September 17, 2025 (incorporated by reference from Exhibit 10.2 to the Registrant's Current Report on Form 8-K, filed with the SEC on September 18, 2025). |
| 21.1  | List of Subsidiaries of Medicus Pharma Ltd. (incorporated by reference from Exhibit 21.1 to the Registrant's Registration Statement on Form F-1, filed with the SEC on May 29, 2024)                                                                                              |
| 23.1^ | Consent of EisnerAmper LLP                                                                                                                                                                                                                                                        |
| 23.2^ | Consent of MNP LLP                                                                                                                                                                                                                                                                |
| 23.3^ | Consent of Bennett Jones LLP (included in Exhibit 5.1)                                                                                                                                                                                                                            |
| 24.1^ | Powers of Attorney (included in the signature page to this Registration Statement)                                                                                                                                                                                                |
| 107^  | Filing fee